Bakul Group

Bakul Group is a leading Indian pharmaceutical conglomerate primarily focused on the development and manufacture of Active Pharmaceutical Ingredients (APIs) and specialty intermediates. Established in 1975, the group has gained global recognition as one of the largest producers of xanthine derivatives, including theobromine, caffeine, and pentoxifylline. The company operates state-of-the-art manufacturing facilities in Maharashtra that comply with international quality standards, serving major pharmaceutical markets worldwide. Their business model encompasses both the supply of bulk actives and contract manufacturing services for global life science partners. Bakul Group's expertise lies in complex chemical synthesis and large-scale industrial production of high-purity medicinal compounds.